140
Views
13
CrossRef citations to date
0
Altmetric
Original

High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma

, , , , , & show all
Pages 1545-1552 | Received 25 Sep 2005, Accepted 02 Jan 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xavier Poiré, Justin Kline, David Grinblatt, Todd Zimmerman, Kathy Conner, Carolyn Muhs, Thomas Gajewski, Koen Van Besien & Sonali M. Smith. (2010) Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas. Leukemia & Lymphoma 51:7, pages 1241-1250.
Read now
Helge Menzel, Andrea Müller, Christoph Von Schilling, Thomas Licht, Christian Peschel & Ulrich Keller. (2008) Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: Analysis of remission induction and stem cell mobilization. Leukemia & Lymphoma 49:7, pages 1337-1344.
Read now

Articles from other publishers (11)

Ahmet Kursad Gunes, Istemi Serin, Ilknur Demir, Serpil Sarifakiogullari, Salih Sertac Durusoy, Dervis Murad Akkurt, Idris Ince, Gulkan Ozkan, Tahir Alper Cinli & Mustafa Pehlivan. (2021) Comparison of mitoxantrone–melphalan and BEAM conditioning regimens in patients with lymphoma. Hematology/Oncology and Stem Cell Therapy.
Crossref
Mahmut Yeral, Pelin Aytan, Burcu Gungor, Can Boga, Ali Unal, Yener Koc, Leylagul Kaynar, Nurhilal Buyukkurt, Bulent Eser & Hakan Ozdoğu. (2020) A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity. Clinical Lymphoma Myeloma and Leukemia 20:10, pages 652-660.
Crossref
Yu Cai, Liping Wan, Juan Yang, Jun Zhu, Jieling Jiang, Su Li, Xianmin Song & Chun Wang. (2019) High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma. Annals of Hematology 98:4, pages 823-831.
Crossref
Jing-Shi Wang, Zhao Wang, Yi-Ni Wang, Lin Wu, Li Fu & Na Wei. (2015) Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma. Indian Journal of Hematology and Blood Transfusion 31:4, pages 426-433.
Crossref
Rieneke van de Ven, Anneke W. Reurs, Pepijn G. J. T. B. Wijnands, Sandra van Wetering, Ada M. Kruisbeek, Erik Hooijberg, George L. Scheffer, Rik J. Scheper & Tanja D. de Gruijl. (2011) Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapy. Cancer Immunology, Immunotherapy 61:2, pages 181-191.
Crossref
Bruno K.L. Duarte, Isabella Valente, Afonso C. Vigorito, Francisco J.P. Aranha, Gislaine Oliveira-Duarte, Eliana C.M. Miranda, Irene Lorand-Metze, Katia B. Pagnano, Marcia Delamain, José F. Marques Junior, Silvia R. Brandalise, Márcio Nucci & Carmino A. De Souza. (2009) Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma. Clinical Lymphoma and Myeloma 9:6, pages 449-454.
Crossref
Paul M Barr & Hillard M Lazarus. (2008) Follicular non-Hodgkin lymphoma: long-term results of stem-cell transplantation. Current Opinion in Oncology 20:5, pages 502-508.
Crossref
M Mimeault, R Hauke & SK Batra. (2007) Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies. Clinical Pharmacology & Therapeutics 83:5, pages 673-691.
Crossref
Mariano Provencio & Luis E. Fayad. (2008) Quimioterapia intensiva y de rescate con progenitores hematopoyéticos autólogos en el tratamiento de los linfomas no hodgkinianos. Medicina Clínica 130:2, pages 60-65.
Crossref
M Mimeault, R Hauke & S K Batra. (2007) Stem Cells: A Revolution in Therapeutics—Recent Advances in Stem Cell Biology and Their Therapeutic Applications in Regenerative Medicine and Cancer Therapies. Clinical Pharmacology & Therapeutics 82:3, pages 252-264.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.